Keyphrases
S6 Kinase 1 (S6K1)
100%
P70S6K
100%
Caspase-3
100%
Proteolytic Cleavage
100%
DNA Damage-induced Apoptosis
100%
Cisplatin
25%
Cisplatin-induced
25%
Induced Apoptosis
16%
MCF-7 Cells
16%
Apoptosis
8%
Protein Translation
8%
Ectopic Expression
8%
Small Interfering RNA (siRNA)
8%
Potentiation
8%
Recombinant
8%
DNA Damage
8%
Small Cell Lung Cancer
8%
Protease Inhibitors
8%
Drug Resistance
8%
Concentration-dependent
8%
Novel Substrates
8%
Caspase Inhibitor
8%
Non-canonical
8%
Site-directed mutagenesis
8%
Cell Cycle Progression
8%
Peptide Inhibitor
8%
Recognition Site
8%
Calpain Inhibitor
8%
Non-small Cell Lung Cancer A549 Cells
8%
Broad-specificity
8%
Cell-penetrating Peptide
8%
Biochemistry, Genetics and Molecular Biology
Kinase
100%
Phosphotransferase
100%
DNA Damage
100%
Caspase 3
100%
Ribosomal S6 Kinase
100%
Cisplatin
50%
Small Interfering RNA
8%
Ectopic Expression
8%
Translation (Protein Synthesis)
8%
N-Terminus
8%
Caspase
8%
Drug Resistance
8%
Recombinant
8%
Site-Directed Mutagenesis
8%
Calpastatin
8%
Cell Cycle Progression
8%
Neuroscience
Caspase 3
100%
DNA Damage
100%
S6 Kinase
100%
Ribosomal S6 Kinase
100%
Cisplatin
50%
In Vitro
8%
Caspase
8%
Small Interfering RNA
8%
Amino Terminal Sequence
8%
Calpain
8%
Ectopic Expression
8%
Drug Resistance
8%
Cell Cycle Progression
8%
A549 Cell
8%
Site-Directed Mutagenesis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Caspase 3
100%
S6 Kinase
100%
Cisplatin
46%
Small Interfering RNA
7%
Recombinant
7%
Small Cell Lung Cancer
7%
Drug Resistance
7%
Caspase Inhibitor
7%
Non Small Cell Lung Cancer
7%
Calpastatin
7%
Site-Directed Mutagenesis
7%
Immunology and Microbiology
DNA Damage
100%
Caspase
100%
Amino Terminal Sequence
14%
Ectopic Expression
14%
Drug Resistance
14%
Site Directed Mutagenesis
14%
Cell Cycle Progression
14%